Compounds > jte 522
Page last updated: 2024-09-04

jte 522 and Angiogenesis, Pathologic

jte 522 has been researched along with Angiogenesis, Pathologic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirose, F; Ikeda, Y; Nakamura, Y; Nishimura, G; Satake, K; Taguchi, T; Tsukuda, M; Yanoma, S1
Amano, H; Hayashi, I; Inukai, M; Kamata, M; Kitasato, H; Majima, M; Yoshida, S; Yoshimura, H1
Enomoto, M; Gonda, T; Higuchi, T; Kobayashi, H; Sugihara, K; Uetake, H1
Asakage, M; Hori, N; Kaisaki, S; Kawai, K; Kitayama, J; Nagawa, H; Okaji, Y; Sunami, E; Takahashi, K; Tsuno, NH; Watanabe, T; Yazawa, K1

Other Studies

4 other study(ies) available for jte 522 and Angiogenesis, Pathologic

ArticleYear
An experimental model of tumor dormancy therapy for advanced head and neck carcinoma.
    Japanese journal of cancer research : Gann, 2000, Volume: 91, Issue:11

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Biotransformation; Cell Division; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Combinations; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Isoenzymes; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Organic Chemicals; Oxonic Acid; Probucol; Prodrugs; Prostaglandin-Endoperoxide Synthases; Pyridines; Tegafur; Telomerase; Xenograft Model Antitumor Assays

2000
COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo.
    Laboratory investigation; a journal of technical methods and pathology, 2003, Volume: 83, Issue:10

    Topics: Animals; Antibodies, Blocking; Aspirin; Benzenesulfonates; Carcinoma, Lewis Lung; Cyclooxygenase Inhibitors; Disease Models, Animal; Endothelial Growth Factors; Intercellular Signaling Peptides and Proteins; Isoxazoles; Lymphokines; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neovascularization, Pathologic; Nitrobenzenes; Oxazoles; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoma 180; Sulfonamides; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003
JTE-522, a selective COX-2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: a vascular cast model study.
    International journal of cancer, 2004, Dec-20, Volume: 112, Issue:6

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzenesulfonates; Cell Line, Tumor; Colorectal Neoplasms; Cyclooxygenase 2; Enzyme Inhibitors; Isoenzymes; Logistic Models; Lung Neoplasms; Male; Microcirculation; Microscopy, Electron, Scanning; Neovascularization, Pathologic; Oxazoles; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Rats; Rats, Inbred F344

2004
Selective inhibition of cyclooxygenase (COX)-2 inhibits endothelial cell proliferation by induction of cell cycle arrest.
    International journal of cancer, 2005, Feb-10, Volume: 113, Issue:4

    Topics: Apoptosis; Benzenesulfonates; Cell Adhesion; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Extracellular Matrix; G1 Phase; Humans; Isoenzymes; Matrix Metalloproteinase 2; Membrane Proteins; Neovascularization, Pathologic; Oxazoles; Prostaglandin-Endoperoxide Synthases; Umbilical Veins

2005